{
  "slug": "vertex",
  "name": "Vertex",
  "description": "Vertex is a global biotechnology company that invests in scientific innovation to discover, develop, and produce transformative medicines for people with serious diseases, including cystic fibrosis, sickle cell disease, beta thalassemia, IgA nephropathy, and type 1 diabetes.",
  "url": "https://optimly.ai/brand/vertex",
  "websiteUrl": "https://vrtx.com/",
  "logoUrl": "https://logo.clearbit.com/vrtx.com",
  "baiScore": null,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "RNA and DNA Targeted Therapies",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-08-30T00:06:12.345Z",
  "verifiedVitals": {
    "website": "https://vrtx.com",
    "category": "Biotechnology company",
    "what_it_does": "Vertex Pharmaceuticals invests in scientific innovation to create transformative medicines for people with serious diseases, focusing on discovering, developing, manufacturing, and commercializing small molecule drugs and gene therapy.",
    "primary_audience": "The primary audience includes patients with serious diseases, specialty pharmacies, distributors, wholesalers, retail pharmacies, hospitals, clinics, clinical trial volunteers, media, and shareholders.",
    "core_product": "Vertex's core products are transformative medicines for serious diseases, including cystic fibrosis (CF) therapies such as TRIKAFTA/KAFTRIO, ALYFTREK, SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO. They also offer CASGEVY, a CRISPR-based therapy for sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT), and are developing treatments for acute pain (JOURNAVX/suzetrigine), APOL1-mediated kidney disease (inaxaplin), and type 1 diabetes (VX-264, VX-880).",
    "pricing_model": {
      "kind": "custom",
      "detail": "Vertex operates a branded biopharma product-sales business, selling premium-priced drugs in relatively low volumes. The pricing is influenced by private insurers, government payers, national health systems, hospitals, specialty pharmacies, and treatment centers."
    },
    "parent_ownership": "Vertex Pharmaceuticals Incorporated is a publicly traded company with widely dispersed ownership and no disclosed controlling shareholder. It is traded on Nasdaq under the ticker VRTX."
  },
  "intentTags": null,
  "businessProfileClaims": [],
  "timestamp": 1788078449380
}